In this article (Clin Cancer Res 2015;21:819–32), which was published in the February 15, 2015, issue of Clinical Cancer Research (1), panels A–C of Fig. 4 are identical to panels A–C of Fig. 3. In addition, the first sentence of the Fig. 4 legend erroneously lists “ES-6”; it should be “EW-5.” A new version of Fig. 4, including the correct versions of panels A–C, and the revised legend are provided below. The authors regret this error.

1.
Smith
MA
,
Reynolds
CP
,
Kang
MH
,
Kolb
EA
,
Gorlick
R
,
Carol
H
, et al
Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing program
.
Clin Cancer Res
2015
;
21
:
819
32
.